Skip to main content

IDWeek 2023 Main banner

Tweets by IDWeek 2023

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

Carla Talarico, PhD, MPH (she/her/hers)

Director
Vaccines and Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD, USA

Poster(s):

(470) Clinical Effectiveness of The Monoclonal Antibody Combination Tixagevimab-Cilgavimab (T/C) as Pre-Exposure Prophylaxis (PReP) of COVID-19 among Patients (pts) with Moderate to Severe Immunocompromised (IC) Conditions across a Large U.S. Healthcare System: A Propensity Score-Matched Retrospective Cohort Study

Thursday, October 12, 2023
12:15 PM - 1:30 PM US ET
(471) In-Depth Characterization of SARS-CoV-2 Variants Causing Breakthrough COVID-19 Among Hospitalized Immunocompromised (IC) Patients with or without Prior Exposure to Tixagevimab-Cilgavimab (T/C) Pre-Exposure Prophylaxis (PrEP)

Thursday, October 12, 2023
12:15 PM - 1:30 PM US ET
(2292) Measuring Effectiveness against a Shifting Variant Landscape: COVID-19 Example in the Department of Veterans Affairs

Saturday, October 14, 2023
12:15 PM - 1:30 PM US ET